The DOI matches its Crossref record; 1,025 of the 1,025 references it cites were found in a registry or an index.
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Open accessAbstract
Glenn N. Levine, MD, FACC, FAHA, Chair Patrick T. O’Gara, MD, MACC, FAHA, Chair-Elect Jonathan L. Halperin, MD, FACC, FAHA, Immediate Past Chair [¶][1] Sana M. Al-Khatib, MD, MHS, FACC, FAHA Joshua A. Beckman, MD, MS, FAHA Kim K. Birtcher, MS, PharmD, AACC Biykem Bozkurt, MD, PhD, FACC,
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Systematic Treatment Approach to Ventricular Tachycardia in Cardiac Sarcoidosis [RETRACTED]
Naruse, Y., Sekiguchi, Y., Nogami, A., Okada, H., Yamauchi, Y., Machino, T., Kuroki, K., Ito, Y., Yamasaki, H., Igarashi, M., et al. (2014) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.000734 · Cited by 122
RetractedHeart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Self-citationThe Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,115
Self-citationMoss, A. J., Zareba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,902
Authors/Task Force Members, Steg, P. G., James, S. K., Atar, D., Badano, L. P., Lundqvist, C. B., Borger, M. A., Di Mario, C., Dickstein, K., Ducrocq, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs215 · Cited by 6,829
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
Cleland, J. G. F., Daubert, J.-C., Erdmann, E., Freemantle, N., Gras, D., Kappenberger, L., & Tavazzi, L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050496 · Cited by 6,276
Bristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., De Marco, T., Carson, P., DiCarlo, L., DeMets, D., White, B. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032423 · Cited by 5,812
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
(1999) · The Lancet · doi:10.1016/s0140-6736(98)11181-9 · Cited by 4,929
WRITING COMMITTEE MEMBERS*, O’Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C., Fesmire, F. M., et al. (2013) · Circulation · doi:10.1161/cir.0b013e3182742cf6 · Cited by 4,725
Self-citationThe Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
Packer, M., Bristow, M. R., Cohn, J. N., Colucci, W. S., Fowler, M. B., Gilbert, E. M., & Shusterman, N. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342101 · Cited by 4,649
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
Owan, T. E., Hodge, D. O., Herges, R. M., Jacobsen, S. J., Roger, V. L., & Redfield, M. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052256 · Cited by 4,191
Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352601 · Cited by 4,165
Charles, C., Gafni, A., & Whelan, T. (1997) · Social Science & Medicine · doi:10.1016/s0277-9536(96)00221-3 · Cited by 4,137
Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., Elliott, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv316 · Cited by 3,893
Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine
Mann, D. L., Zipes, D. P., Libby, P., Bonow, R. O., & D, E. B. M. (2011) · Medical Entomology and Zoology · Cited by 3,745
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H., Kelly, R. F., Kontos, M. C., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.017 · Cited by 3,595
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.536 · Cited by 3,523
Caforio, A. L. P., Pankuweit, S., Arbustini, E., Basso, C., Gimeno-Blanes, J., Felix, S. B., Fu, M., Heliö, T., Heymans, S., Jahns, R., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht210 · Cited by 3,479
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.025 · Cited by 3,418
Self-citationNishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.011 · Cited by 3,339
Writing Committee Members, Levine, G. N., Bates, E. R., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31823ba622 · Cited by 3,289
Echt, D. S., Liebson, P. R., Mitchell, L. B., Peters, R. W., Obias-Manno, D., Barker, A. H., Arensberg, D., Baker, A., Friedman, L., Greene, H. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241201 · Cited by 3,253
(1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372202 · Cited by 3,232
Eplerenone in patients with systolic heart failure and mild symptoms
Zannad, F., McMurray, J. J. V., Krum, H., van Veldhuisen, D. J., Swedberg, K., Shi, H., Vincent, J., Pocock, S. J., & Pitt, B. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009492 · Cited by 3,111
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
Cohn, J. N., & Tognoni, G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010713 · Cited by 3,108
Clinical Practice Guidelines We Can Trust
Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Board on Health Care Services, & Institute of Medicine (2011) · National Academies Press eBooks · doi:10.17226/13058 · Cited by 3,081
Sanders, G. D., Neumann, P. J., Basu, A., Brock, D. W., Feeny, D., Krahn, M., Kuntz, K. M., Meltzer, D. O., Owens, D. K., Prosser, L. A., et al. (2016) · JAMA · doi:10.1001/jama.2016.12195 · Cited by 3,069
Yusuf, S., Pfeffer, M. A., Swedberg, K., Granger, C. B., Held, P., McMurray, J. J., Michelson, E. L., Olofsson, B., & Östergren, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14285-7 · Cited by 2,994
Self-citation2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.022 · Cited by 2,955
Self-citationNishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000031 · Cited by 2,905
Cohn, J. N., Johnson, G., Ziesche, S., Cobb, F., Francis, G., Tristani, F., Smith, R., Dunkman, W. B., Loeb, H., Wong, M., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250502 · Cited by 2,833
Spironolactone for heart failure with preserved ejection fraction
Pitt, B., Pfeffer, M. A., Assmann, S. F., Boineau, R., Anand, I. S., Claggett, B., Clausell, N., Desai, A. S., Diaz, R., Fleg, J. L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1313731 · Cited by 2,809
Marcus, F. I., McKenna, W. J., Sherrill, D., Basso, C., Bauce, B., Bluemke, D. A., Calkins, H., Corrado, D., Cox, M. G. P. J., Daubert, J. P., et al. (2010) · Circulation · doi:10.1161/circulationaha.108.840827 · Cited by 2,676
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs105 · Cited by 2,644
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
O'Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C., Fesmire, F. M., Franklin, B. A., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.019 · Cited by 2,625
Self-citationMcMurray, J. J., Östergren, J., Swedberg, K., Granger, C. B., Held, P., Michelson, E. L., Olofsson, B., Yusuf, S., & Pfeffer, M. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14283-3 · Cited by 2,604
Self-citationJacobs, I., Nadkarni, V., the ILCOR Task Force on Cardiac Arrest and Cardiopulmonary Resuscitation Outcomes, PARTICIPANTS, C., Bahr, J., Berg, R. A., Billi, J. E., Bossaert, L., Cassan, P., Coovadia, A., et al. (2004) · Circulation · doi:10.1161/01.cir.0000147236.85306.15 · Cited by 2,560
ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities
Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N. A. M., Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.02.032 · Cited by 2,546
Self-citationA Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease
Buxton, A. E., Lee, K. L., Fisher, J. D., Josephson, M. E., Prystowsky, E. N., & Hafley, G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912163412503 · Cited by 2,489
Pfeffer, M. A., McMurray, J. J. V., Velazquez, E. J., Rouleau, J.-L., Køber, L., Maggioni, A. P., Solomon, S. D., Swedberg, K., Van de Werf, F., White, H., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa032292 · Cited by 2,471
O’Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C., Fesmire, F. M., Franklin, B. A., et al. (2013) · Circulation · doi:10.1161/cir.0b013e3182742c84 · Cited by 2,250
Self-citationGersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e2bd · Cited by 2,104
Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy
Kadish, A., Dyer, A., Daubert, J. P., Quigg, R., Estes, N. A. M., Anderson, K. P., Calkins, H., Hoch, D., Goldberger, J., Shalaby, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033088 · Cited by 2,080
Sudden Deaths in Young Competitive Athletes: Analysis of 1866 Deaths in the United States, 1980–2006
Maron, B. J., Doerer, J. J., Haas, T. S., Tierney, D. M., & Mueller, F. O. (2009) · Circulation · doi:10.1161/circulationaha.108.804617 · Cited by 2,078
Predictors of Survival From Out-of-Hospital Cardiac Arrest: A Systematic Review and Meta-Analysis
Sasson, C., Rogers, M. A. M., Dahl, J., & Kellermann, A. L. (2010) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.109.889576 · Cited by 2,064
Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Myerburg, R. J., Quinones, M. A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.010 · Cited by 1,973
Self-citationFish Intake, Contaminants, and Human Health: Evaluating the Risks and the Benefits
Mozaffarian, D., & Rimm, E. B. (2006) · JAMA · doi:10.1001/jama.296.15.1885 · Cited by 1,966
Drug-induced prolongation of the QT interval
Roden, D. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032426 · Cited by 1,965
Irbesartan in patients with heart failure and preserved ejection fraction
Massie, B. M., Carson, P. E., McMurray, J. J., Komajda, M., McKelvie, R., Zile, M. R., Anderson, S., Donovan, M., Iverson, E., Staiger, C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805450 · Cited by 1,960
Priori, S. G., Wilde, A. A., Horie, M., Cho, Y., Behr, E. R., Berul, C., Blom, N., Brugada, J., Chiang, C.-E., Huikuri, H., et al. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.05.014 · Cited by 1,942
Writing Committee Members, Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N. A. M., Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., et al. (2008) · Circulation · doi:10.1161/circualtionaha.108.189742 · Cited by 1,774
Self-citationDefibrillator implantation in patients with nonischemic systolic heart failure
Køber, L., Thune, J. J., Nielsen, J. C., Haarbo, J., Videbæk, L., Korup, E., Jensen, G., Hildebrandt, P., Steffensen, F. H., Bruun, N. E., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1608029 · Cited by 1,763
Smith, S. C., Benjamin, E. J., Bonow, R. O., Braun, L. T., Creager, M. A., Franklin, B. A., Gibbons, R. J., Grundy, S. M., Hiratzka, L. F., Jones, D. W., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318235eb4d · Cited by 1,759
Neumar, R. W., Otto, C. W., Link, M. S., Kronick, S. L., Shuster, M., Callaway, C. W., Kudenchuk, P. J., Ornato, J. P., McNally, B., Silvers, S. M., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.970988 · Cited by 1,634
Connolly, S. J., Gent, M., Roberts, R. S., Dorian, P., Roy, D., Sheldon, R. S., Mitchell, L. B., Green, M. S., Klein, G. J., & O’Brien, B. (2000) · Circulation · doi:10.1161/01.cir.101.11.1297 · Cited by 1,607
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction
Hohnloser, S. H., Kuck, K. H., Dorian, P., Roberts, R. S., Hampton, J. R., Hatala, R., Fain, E., Gent, M., & Connolly, S. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041489 · Cited by 1,519
Rosuvastatin in older patients with systolic heart failure
Kjekshus, J., Apetrei, E., Barrios, V., Böhm, M., Cleland, J. G. F., Cornel, J. H., Dunselman, P., Fonseca, C., Goudev, A., Grande, P., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706201 · Cited by 1,487
Outcomes of Rapid Defibrillation by Security Officers after Cardiac Arrest in Casinos
Valenzuela, T. D., Roe, D. J., Nichol, G., Clark, L. L., Spaite, D. W., & Hardman, R. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010263431701 · Cited by 1,485
Kuck, K.-H., Cappato, R., Siebels, J., & Rüppel, R. (2000) · Circulation · doi:10.1161/01.cir.102.7.748 · Cited by 1,482
Ackerman, M. J., Priori, S. G., Willems, S., Berul, C., Brugada, R., Calkins, H., Camm, A. J., Ellinor, P. T., Gollob, M., Hamilton, R., et al. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.05.020 · Cited by 1,479
Self-citationBirnie, D. H., Sauer, W. H., Bogun, F., Cooper, J. M., Culver, D. A., Duvernoy, C. S., Judson, M. A., Kron, J., Mehta, D., Cosedis Nielsen, J., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.03.043 · Cited by 1,479
Sudden Death Due to Cardiac Arrhythmias
Huikuri, H. V., Castellanos, A., & Myerburg, R. J. (2001) · New England Journal of Medicine · doi:10.1056/nejmra000650 · Cited by 1,466
Self-citationRisk Stratification in the Long-QT Syndrome
Priori, S. G., Schwartz, P. J., Napolitano, C., Bloise, R., Ronchetti, E., Grillo, M., Vicentini, A., Spazzolini, C., Nastoli, J., Bottelli, G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022147 · Cited by 1,459
Hjalmarson, Å., Goldstein, S., Fagerberg, B., Wedel, H., Waagstein, F., Kjekshus, J., Wikstrand, J., El Allaf, D., Vítovec, J., Aldershvile, J., et al. (2000) · JAMA · doi:10.1001/jama.283.10.1295 · Cited by 1,399
Waldo, A. L., Camm, A. J., deRuyter, H., Friedman, P. L., MacNeil, D. J., Pauls, J. F., Pitt, B., Pratt, C. M., Schwartz, P. J., & Veltri, E. P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)02149-6 · Cited by 1,371
Incidence and Prognosis of Syncope
Soteriades, E. S., Evans, J. C., Larson, M. G., Chen, M. H., Chen, L., Benjamin, E. J., & Levy, D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012407 · Cited by 1,364
Marchioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., Franzosi, M. G., Geraci, E., Levantesi, G., Maggioni, A. P., et al. (2002) · Circulation · doi:10.1161/01.cir.0000014682.14181.f2 · Cited by 1,311
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.011 · Cited by 1,276
O'Mahony, C., Jichi, F., Pavlou, M., Monserrat, L., Anastasakis, A., Rapezzi, C., Biagini, E., Gimeno, J. R., Limongelli, G., McKenna, W. J., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht439 · Cited by 1,251
Effect of Statins on Risk of Coronary Disease: A Meta-analysis of Randomized Controlled Trials
LaRosa, J. C., He, J., & Vupputuri, S. (1999) · JAMA · doi:10.1001/jama.282.24.2340 · Cited by 1,246
Amiodarone in Patients with Congestive Heart Failure and Asymptomatic Ventricular Arrhythmia
Singh, S. N., Fletcher, R. D., Fisher, S. G., Singh, B. N., Lewis, H. D., Deedwania, P. C., Massie, B. M., Colling, C., & Lazzeri, D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507133330201 · Cited by 1,225
Priori, S. G., Napolitano, C., Memmi, M., Colombi, B., Drago, F., Gasparini, M., DeSimone, L., Coltorti, F., Bloise, R., Keegan, R., et al. (2002) · Circulation · doi:10.1161/01.cir.0000020013.73106.d8 · Cited by 1,173
Cardiovascular Magnetic Resonance, Fibrosis, and Prognosis in Dilated Cardiomyopathy
Assomull, R. G., Prasad, S. K., Lyne, J., Smith, G., Burman, E. D., Khan, M., Sheppard, M. N., Poole-Wilson, P. A., & Pennell, D. J. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.049 · Cited by 1,164
Link, M. S., Berkow, L. C., Kudenchuk, P. J., Halperin, H. R., Hess, E. P., Moitra, V. K., Neumar, R. W., O’Neil, B. J., Paxton, J. H., Silvers, S. M., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000261 · Cited by 1,150
Magnitude of Left Ventricular Hypertrophy and Risk of Sudden Death in Hypertrophic Cardiomyopathy
Spirito, P., Bellone, P., Harris, K. M., Bernabò, P., Bruzzi, P., & Maron, B. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422403 · Cited by 1,143
Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials
Connolly, S. (2000) · European Heart Journal · doi:10.1053/euhj.2000.2476 · Cited by 1,126
GISSI-HF investigators (2008) · The Lancet · doi:10.1016/s0140-6736(08)61240-4 · Cited by 1,106
Aliskiren, ALTITUDE, and the Implications for ATMOSPHERE
McMurray, J. J. V., Abraham, W. T., Dickstein, K., Køber, L., Massie, B. M., & Krum, H. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs033 · Cited by 1,096
Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy
Velazquez, E. J., Lee, K. L., Jones, R. H., Al-Khalidi, H. R., Hill, J. A., Panza, J. A., Michler, R. E., Bonow, R. O., Doenst, T., Petrie, M. C., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602001 · Cited by 1,074
Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H., Kelly, R. F., Kontos, M. C., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000134 · Cited by 1,059
Natural History of Brugada Syndrome: Insights for Risk Stratification and Management
Priori, S. G., Napolitano, C., Gasparini, M., Pappone, C., Bella, P. D., Giordano, U., Bloise, R., Giustetto, C., De Nardis, R., Grillo, M., et al. (2002) · Circulation · doi:10.1161/hc1102.105288 · Cited by 1,034
Perkins, G. D., Jacobs, I. G., Nadkarni, V. M., Berg, R. A., Bhanji, F., Biarent, D., Bossaert, L. L., Brett, S. J., Chamberlain, D., de Caen, A. R., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000144 · Cited by 1,031
Bigger, J. T. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372201 · Cited by 1,020
Catecholaminergic Polymorphic Ventricular Tachycardia in Children: A 7-Year Follow-up of 21 Patients
Leenhardt, A., Lucet, V., Denjoy, I., Grau, F., Ngoc, D. D., & Coumel, P. (1995) · Circulation · doi:10.1161/01.cir.91.5.1512 · Cited by 1,010
Effect of the Antiarrhythmic Agent Moricizine on Survival after Myocardial Infarction
(1992) · New England Journal of Medicine · doi:10.1056/nejm199207233270403 · Cited by 1,005
Yan, G.-X., & Antzelevitch, C. (1998) · Circulation · doi:10.1161/01.cir.98.18.1928 · Cited by 988
Corrado, D., Basso, C., Thiene, G., McKenna, W. J., Davies, M. J., Fontaliran, F., Nava, A., Silvestri, F., Blomstrom-Lundqvist, C., Wlodarska, E. K., et al. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00332-x · Cited by 978
Sudden death in hypertrophic cardiomyopathy: identification of high risk patients
Elliott, P. M., Poloniecki, J., Dickie, S., Sharma, S., Monserrat, L., Varnava, A., Mahon, N. G., & McKenna, W. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01003-2 · Cited by 978
Female Gender as a Risk Factor for Torsades de Pointes Associated With Cardiovascular Drugs
Makkar, R. R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510210076031 · Cited by 971
Immediate Coronary Angiography in Survivors of Out-of-Hospital Cardiac Arrest
Spaulding, C. M., Joly, L.-M., Rosenberg, A., Monchi, M., Weber, S. N., Dhainaut, J.-F. A., & Carli, P. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706053362302 · Cited by 955
Finding What Works in Health Care: Standards for Systematic Reviews
Eden, J., Levit, L. A., Berg, A. O., & Morton, S. C. (2013) · Cited by 943
n–3 Fatty Acids and Cardiovascular Events after Myocardial Infarction
Kromhout, D., Giltay, E. J., & Geleijnse, J. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003603 · Cited by 936
n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
The ORIGIN Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203859 · Cited by 929
Smith, S. C., Benjamin, E. J., Bonow, R. O., Braun, L. T., Creager, M. A., Franklin, B. A., Gibbons, R. J., Grundy, S. M., Hiratzka, L. F., Jones, D. W., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.10.824 · Cited by 910
WRITING COMMITTEE MEMBERS, Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G., Fonarow, G. C., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000435 · Cited by 897
Self-citationAckerman, M. J., Priori, S. G., Willems, S., Berul, C., Brugada, R., Calkins, H., Camm, A. J., Ellinor, P. T., Gollob, M., Hamilton, R., et al. (2011) · Europace · doi:10.1093/europace/eur245 · Cited by 895
Self-citationLong-Term Outcome of Fulminant Myocarditis as Compared with Acute (Nonfulminant) Myocarditis
McCarthy, R. E., Boehmer, J. P., Hruban, R. H., Hutchins, G. M., Kasper, E. K., Hare, J. M., & Baughman, K. L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421003 · Cited by 877
Role of the Autonomic Nervous System in Modulating Cardiac Arrhythmias
Shen, M. J., & Zipes, D. P. (2014) · Circulation Research · doi:10.1161/circresaha.113.302549 · Cited by 867
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs
Sapp, J. L., Wells, G. A., Parkash, R., Stevenson, W. G., Blier, L., Sarrazin, J.-F., Thibault, B., Rivard, L., Gula, L., Leong-Sit, P., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1513614 · Cited by 863
Self-citationSudden cardiac death associated with isolated congenital coronary artery anomalies
Taylor, A. J., Rogan, K. M., & Virmani, R. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90019-j · Cited by 849
Probst, V., Veltmann, C., Eckardt, L., Meregalli, P. G., Gaita, F., Tan, H. L., Babuty, D., Sacher, F., Giustetto, C., Schulze-Bahr, E., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.887026 · Cited by 847
Long-Term Outcome Associated with Early Repolarization on Electrocardiography
Tikkanen, J. T., Anttonen, O., Junttila, M. J., Aro, A. L., Kerola, T., Rissanen, H. A., Reunanen, A., & Huikuri, H. V. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0907589 · Cited by 845
A Prospective Study of Sudden Cardiac Death among Children and Young Adults
Bagnall, R. D., Weintraub, R. G., Ingles, J., Duflou, J., Yeates, L., Lam, L., Davis, A. M., Thompson, T., Connell, V., Wallace, J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1510687 · Cited by 845
Effectiveness and Limitations of β-Blocker Therapy in Congenital Long-QT Syndrome
Moss, A. J., Zareba, W., Hall, W. J., Schwartz, P. J., Crampton, R. S., Benhorin, J., Vincent, G. M., Locati, E. H., Priori, S. G., Napolitano, C., et al. (2000) · Circulation · doi:10.1161/01.cir.101.6.616 · Cited by 841
Advanced Cardiac Life Support in Out-of-Hospital Cardiac Arrest
Stiell, I. G., Wells, G. A., Field, B., Spaite, D. W., Nesbitt, L. P., De Maio, V. J., Nichol, G., Cousineau, D., Blackburn, J., Munkley, D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040325 · Cited by 835
Maron, B. J., Shen, W.-K., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Bardy, G. H., Favale, S., Rea, R. F., Boriani, G., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420601 · Cited by 832
Prognostic Significance of Myocardial Fibrosis in Hypertrophic Cardiomyopathy
O'Hanlon, R., Grasso, A., Roughton, M., Moon, J. C., Clark, S., Wage, R., Webb, J., Kulkarni, M., Dawson, D., Sulaibeekh, L., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.010 · Cited by 825
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery
Hillis, L. D., Smith, P. K., Anderson, J. L., Bittl, J. A., Bridges, C. R., Byrne, J. G., Cigarroa, J. E., DiSesa, V. J., Hiratzka, L. F., Hutter, A. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.009 · Cited by 820
A Classification of Antiarrhythmic Actions Reassessed After a Decade of New Drugs
WILLIAMS, E. M. V. (1984) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1984.tb01822.x · Cited by 818
Amiodarone as Compared with Lidocaine for Shock-Resistant Ventricular Fibrillation
Dorian, P., Cass, D., Schwartz, B., Cooper, R., Gelaznikas, R., & Barr, A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013029 · Cited by 810
Amiodarone for Resuscitation after Out-of-Hospital Cardiac Arrest Due to Ventricular Fibrillation
Kudenchuk, P. J., Cobb, L. A., Copass, M. K., Cummins, R. O., Doherty, A. M., Fahrenbruch, C. E., Hallstrom, A. P., Murray, W. A., Olsufka, M., & Walsh, T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411203 · Cited by 809
Maron, B. J., Spirito, P., Shen, W.-K., Haas, T. S., Formisano, F., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Lawrenz, T., et al. (2007) · JAMA · doi:10.1001/jama.298.4.405 · Cited by 804
Public Use of Automated External Defibrillators
Caffrey, S. L., Willoughby, P. J., Pepe, P. E., & Becker, L. B. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020932 · Cited by 800
Baldasseroni, S., Opasich, C., Gorini, M., Lucci, D., Marchionni, N., Marini, M., Campana, C., Perini, G., Deorsola, A., Masotti, G., et al. (2002) · American Heart Journal · doi:10.1067/mhj.2002.121264 · Cited by 800
Kuck, K.-H., Schaumann, A., Eckardt, L., Willems, S., Ventura, R., Delacrétaz, E., Pitschner, H.-F., Kautzner, J., Schumacher, B., & Hansen, P. S. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61755-4 · Cited by 799
Solomon, S. D., Zelenkofske, S., McMurray, J. J. V., Finn, P. V., Velazquez, E., Ertl, G., Harsanyi, A., Rouleau, J. L., Maggioni, A., Kober, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043938 · Cited by 793
Gatzoulis, M. A., Till, J. A., Somerville, J., & Redington, A. N. (1995) · Circulation · doi:10.1161/01.cir.92.2.231 · Cited by 786
Writing Committee Members, Hillis, L. D., Smith, P. K., Anderson, J. L., Bittl, J. A., Bridges, C. R., Byrne, J. G., Cigarroa, J. E., DiSesa, V. J., Hiratzka, L. F., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31823c074e · Cited by 781
An Entirely Subcutaneous Implantable Cardioverter–Defibrillator
Bardy, G. H., Smith, W. M., Hood, M. A., Crozier, I. G., Melton, I. C., Jordaens, L., Theuns, D., Park, R. E., Wright, D. J., Connelly, D. T., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909545 · Cited by 780
Hypertrophic Cardiomyopathy: Clinical Spectrum and Treatment
Wigle, E. D., Rakowski, H., Kimball, B. P., & Williams, W. G. (1995) · Circulation · doi:10.1161/01.cir.92.7.1680 · Cited by 778
Brugada, R., Brugada, J., Antzelevitch, C., Kirsch, G. E., Potenza, D., Towbin, J. A., & Brugada, P. (2000) · Circulation · doi:10.1161/01.cir.101.5.510 · Cited by 772
EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias
Aliot, E. M., Stevenson, W. G., Almendral-Garrote, J. M., Bogun, F., Calkins, C. H., Delacretaz, E., Della Bella, P., Hindricks, G., Jaïs, P., Josephson, M. E., et al. (2009) · Heart Rhythm · doi:10.1016/j.hrthm.2009.04.030 · Cited by 770
Self-citationMoon, J. C. C., McKenna, W. J., McCrohon, J. A., Elliott, P. M., Smith, G. C., & Pennell, D. J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00189-x · Cited by 766
Nademanee, K., Veerakul, G., Chandanamattha, P., Chaothawee, L., Ariyachaipanich, A., Jirasirirojanakorn, K., Likittanasombat, K., Bhuripanyo, K., & Ngarmukos, T. (2011) · Circulation · doi:10.1161/circulationaha.110.972612 · Cited by 762
Niimura, H., Bachinski, L. L., Sangwatanaroj, S., Watkins, H., Chudley, A. E., McKenna, W., Kristinsson, A., Roberts, R., Sole, M., Maron, B. J., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804303381802 · Cited by 761
Kapplinger, J. D., Tester, D. J., Alders, M., Benito, B., Berthet, M., Brugada, J., Brugada, P., Fressart, V., Guerchicoff, A., Harris-Kerr, C., et al. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2009.09.069 · Cited by 761
Self-citationIdiopathic Giant-Cell Myocarditis — Natural History and Treatment
Cooper, L. T., Berry, G. J., & Shabetai, R. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706263362603 · Cited by 757
Sagar, S., Liu, P. P., & Cooper, L. T. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60648-x · Cited by 743
Dumas, F., Cariou, A., Manzo-Silberman, S., Grimaldi, D., Vivien, B., Rosencher, J., Empana, J.-P., Carli, P., Mira, J.-P., Jouven, X., et al. (2010) · Circulation: Cardiovascular Interventions · doi:10.1161/circinterventions.109.913665 · Cited by 739
A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex
Brugada, P., Brugada, J., Mont, L., Smeets, J., & Andries, E. W. (1991) · Circulation · doi:10.1161/01.cir.83.5.1649 · Cited by 738
Stevenson, W. G., Wilber, D. J., Natale, A., Jackman, W. M., Marchlinski, F. E., Talbert, T., Gonzalez, M. D., Worley, S. J., Daoud, E. G., Hwang, C., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.788604 · Cited by 732
Self-citationCobb, L. A. (1999) · JAMA · doi:10.1001/jama.281.13.1182 · Cited by 730
Quill, T. E., & Brody, H. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-9-199611010-00010 · Cited by 723
Vanden Hoek, T. L., Morrison, L. J., Shuster, M., Donnino, M., Sinz, E., Lavonas, E. J., Jeejeebhoy, F. M., & Gabrielli, A. (2010) · Circulation · doi:10.1161/circulationaha.110.971069 · Cited by 720
James, C. A., Bhonsale, A., Tichnell, C., Murray, B., Russell, S. D., Tandri, H., Tedford, R. J., Judge, D. P., & Calkins, H. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.06.033 · Cited by 710
Khairy, P., Van Hare, G. F., Balaji, S., Berul, C. I., Cecchin, F., Cohen, M. I., Daniels, C. J., Deal, B. J., Dearani, J. A., Groot, N. D., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.05.009 · Cited by 709
Self-citationBlankstein, R., Osborne, M., Naya, M., Waller, A., Kim, C. K., Murthy, V. L., Kazemian, P., Kwong, R. Y., Tokuda, M., Skali, H., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.022 · Cited by 709
Self-citationB-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart Failure
Berger, R., Huelsman, M., Strecker, K., Bojic, A., Moser, P., Stanek, B., & Pacher, R. (2002) · Circulation · doi:10.1161/01.cir.0000016642.15031.34 · Cited by 706
Genetic Evaluation of Cardiomyopathy—A Heart Failure Society of America Practice Guideline
Hershberger, R. E., Lindenfeld, J., Mestroni, L., Seidman, C. E., Taylor, M. R. G., & Towbin, J. A. (2009) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2009.01.006 · Cited by 702
Defibrillator implantation early after myocardial infarction
Steinbeck, G., Andresen, D., Seidl, K., Brachmann, J., Hoffmann, E., Wojciechowski, D., Kornacewicz-Jach, Z., Sredniawa, B., Lupkovics, G., Hofgärtner, F., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901889 · Cited by 690
Mapping and Ablation of Idiopathic Ventricular Fibrillation
Haïssaguerre, M., Shoda, M., Jaïs, P., Nogami, A., Shah, D. C., Kautzner, J., Arentz, T., Kalushe, D., Lamaison, D., Griffith, M., et al. (2002) · Circulation · doi:10.1161/01.cir.0000027564.55739.b1 · Cited by 686
Schwartz, P. J., Priori, S. G., Cerrone, M., Spazzolini, C., Odero, A., Napolitano, C., Bloise, R., De Ferrari, G. M., Klersy, C., Moss, A. J., et al. (2004) · Circulation · doi:10.1161/01.cir.0000125523.14403.1e · Cited by 686
Predictors of Outcome in Patients With Suspected Myocarditis
Kindermann, I., Kindermann, M., Kandolf, R., Klingel, K., Bültmann, B., Müller, T., Lindinger, A., & Böhm, M. (2008) · Circulation · doi:10.1161/circulationaha.108.769489 · Cited by 683
Relationship between burden of premature ventricular complexes and left ventricular function
Baman, T. S., Lange, D. C., Ilg, K. J., Gupta, S. K., Liu, T.-Y., Alguire, C., Armstrong, W., Good, E., Chugh, A., Jongnarangsin, K., et al. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.03.036 · Cited by 676
Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair
Therrien, J., Provost, Y., Merchant, N., Williams, W., Colman, J., & Webb, G. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.11.037 · Cited by 664
Yazaki, Y., Isobe, M., Hiroe, M., Morimoto, S.-I., Hiramitsu, S., Nakano, T., Izumi, T., & Sekiguchi, M. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01978-6 · Cited by 664
Left-Dominant Arrhythmogenic Cardiomyopathy
Sen-Chowdhry, S., Syrris, P., Prasad, S. K., Hughes, S. E., Merrifield, R., Ward, D., Pennell, D. J., & McKenna, W. J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.09.019 · Cited by 661
Ventricular Premature Beats and Mortality after Myocardial Infarction
Ruberman, W., Weinblatt, E., Goldberg, J. D., Frank, C. W., & Shapiro, S. (1977) · New England Journal of Medicine · doi:10.1056/nejm197710062971404 · Cited by 660
Guiding Principles for the Care of Older Adults with Multimorbidity: An Approach for Clinicians
American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.04188.x · Cited by 660
Klues, H. G., Schiffers, A., & Maron, B. J. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00390-8 · Cited by 656
Wik, L., Hansen, T. B., Fylling, F., Steen, T., Vaagenes, P., Auestad, B. H., & Steen, P. A. (2003) · JAMA · doi:10.1001/jama.289.11.1389 · Cited by 646
Bänsch, D., Antz, M., Boczor, S., Volkmer, M., Tebbenjohanns, J., Seidl, K., Block, M., Gietzen, F., Berger, J., & Kuck, K. H. (2002) · Circulation · doi:10.1161/01.cir.0000012350.99718.ad · Cited by 646
Diller, G.-P., Kempny, A., Alonso-Gonzalez, R., Swan, L., Uebing, A., Li, W., Babu-Narayan, S., Wort, S. J., Dimopoulos, K., & Gatzoulis, M. A. (2015) · Circulation · doi:10.1161/circulationaha.115.017202 · Cited by 639
Resuscitation After Cardiac Arrest: A 3-Phase Time-Sensitive Model
Weisfeldt, M. L., & Becker, L. B. (2002) · JAMA · doi:10.1001/jama.288.23.3035 · Cited by 637
Use of Automated External Defibrillators by a U.S. Airline
Page, R. L., Joglar, J. A., Kowal, R. C., Zagrodzky, J. D., Nelson, L. L., Ramaswamy, K., Barbera, S. J., Hamdan, M. H., & McKenas, D. K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010263431702 · Cited by 632
Self-citationBrodsky, M., Wu, D., Denes, P., Kanakis, C., & Rosen, K. M. (1977) · The American Journal of Cardiology · doi:10.1016/s0002-9149(77)80094-5 · Cited by 628
Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death
Basso, C., Perazzolo Marra, M., Rizzo, S., De Lazzari, M., Giorgi, B., Cipriani, A., Frigo, A. C., Rigato, I., Migliore, F., Pilichou, K., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.016291 · Cited by 625
Mortality in adult congenital heart disease
Verheugt, C. L., Uiterwaal, C. S. P. M., van der Velde, E. T., Meijboom, F. J., Pieper, P. G., van Dijk, A. P. J., Vliegen, H. W., Grobbee, D. E., & Mulder, B. J. M. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq032 · Cited by 617
Fishman, G. I., Chugh, S. S., DiMarco, J. P., Albert, C. M., Anderson, M. E., Bonow, R. O., Buxton, A. E., Chen, P.-S., Estes, M., Jouven, X., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.976092 · Cited by 614
Self-citationTreatment of torsade de pointes with magnesium sulfate.
Tzivoni, D., Banai, S., Schuger, C., Benhorin, J., Keren, A., Gottlieb, S., & Stern, S. (1988) · Circulation · doi:10.1161/01.cir.77.2.392 · Cited by 614
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G., Fonarow, G. C., Givertz, M. M., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.05.011 · Cited by 613
Self-citationFlecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans
Watanabe, H., Chopra, N., Laver, D., Hwang, H. S., Davies, S. S., Roach, D. E., Duff, H. J., Roden, D. M., Wilde, A. A. M., & Knollmann, B. C. (2009) · Nature Medicine · doi:10.1038/nm.1942 · Cited by 608
Teo, K. K. (1993) · JAMA · doi:10.1001/jama.270.13.1589 · Cited by 608
Rauch, B., Schiele, R., Schneider, S., Diller, F., Victor, N., Gohlke, H., Gottwik, M., Steinbeck, G., Del Castillo, U., Sack, R., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.948562 · Cited by 607
Leaf, A., Kang, J. X., Xiao, Y.-F., & Billman, G. E. (2003) · Circulation · doi:10.1161/01.cir.0000069566.78305.33 · Cited by 605
(2005) · New England Journal of Medicine · doi:10.1056/nejm200508183530725 · Cited by 602
Association of Long QT Syndrome Loci and Cardiac Events Among Patients Treated With β-Blockers
Priori, S. G. (2004) · JAMA · doi:10.1001/jama.292.11.1341 · Cited by 601
Page, R. L., Joglar, J. A., Caldwell, M. A., Calkins, H., Conti, J. B., Deal, B. J., Estes, N. A. M., Field, M. E., Goldberger, Z. D., Hammill, S. C., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000311 · Cited by 595
Self-citationCorrado, D., Leoni, L., Link, M. S., Bella, P. D., Gaita, F., Curnis, A., Salerno, J. U., Igidbashian, D., Raviele, A., Disertori, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000103130.33451.d2 · Cited by 587
Strickberger, S. A., Hummel, J. D., Bartlett, T. G., Frumin, H. I., Schuger, C. D., Beau, S. L., Bitar, C., & Morady, F. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00297-3 · Cited by 586
Cardiac Sarcoidosis: Epidemiology, Characteristics, and Outcome Over 25 Years in a Nationwide Study
Kandolin, R., Lehtonen, J., Airaksinen, J., Vihinen, T., Miettinen, H., Ylitalo, K., Kaikkonen, K., Tuohinen, S., Haataja, P., Kerola, T., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.011522 · Cited by 582
Risk Stratification in Brugada Syndrome
Priori, S. G., Gasparini, M., Napolitano, C., Della Bella, P., Ottonelli, A. G., Sassone, B., Giordano, U., Pappone, C., Mascioli, G., Rossetti, G., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.064 · Cited by 581
Harmon, K. G., Asif, I. M., Maleszewski, J. J., Owens, D. S., Prutkin, J. M., Salerno, J. C., Zigman, M. L., Ellenbogen, R., Rao, A. L., Ackerman, M. J., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.015431 · Cited by 577
Self-citationDiverse mechanisms of unexpected cardiac arrest in advanced heart failure.
Luu, M., Stevenson, W. G., Stevenson, L. W., Baron, K., & Walden, J. (1989) · Circulation · doi:10.1161/01.cir.80.6.1675 · Cited by 569
Self-citationMaron, M. S., Finley, J. J., Bos, J. M., Hauser, T. H., Manning, W. J., Haas, T. S., Lesser, J. R., Udelson, J. E., Ackerman, M. J., & Maron, B. J. (2008) · Circulation · doi:10.1161/circulationaha.108.781401 · Cited by 567
Self-citationJ-Point Elevation in Survivors of Primary Ventricular Fibrillation and Matched Control Subjects
Rosso, R., Kogan, E., Belhassen, B., Rozovski, U., Scheinman, M. M., Zeltser, D., Halkin, A., Steinvil, A., Heller, K., Glikson, M., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.010 · Cited by 566
What Causes Sudden Death in Heart Failure?
Tomaselli, G. F., & Zipes, D. P. (2004) · Circulation Research · doi:10.1161/01.res.0000145047.14691.db · Cited by 566
Buxton, A. E., Lee, K. L., DiCarlo, L., Gold, M. R., Greer, G. S., Prystowsky, E. N., O'Toole, M. F., Tang, A., Fisher, J. D., Coromilas, J., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006293422602 · Cited by 566
Silka, M. J., Hardy, B. G., Menashe, V. D., & Morris, C. D. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00187-9 · Cited by 560
Implantable Cardioverter-Defibrillators in Tetralogy of Fallot
Khairy, P., Harris, L., Landzberg, M. J., Viswanathan, S., Barlow, A., Gatzoulis, M. A., Fernandes, S. M., Beauchesne, L., Therrien, J., Chetaille, P., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.726372 · Cited by 557
Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator
Weiss, R., Knight, B. P., Gold, M. R., Leon, A. R., Herre, J. M., Hood, M., Rashtian, M., Kremers, M., Crozier, I., Lee, K. L., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.003042 · Cited by 557
Repetitive monomorphic ventricular tachycardia originating from the aortic sinus cusp
Ouyang, F., Fotuhi, P., Ho, S. Y., Hebe, J., Volkmer, M., Goya, M., Burns, M., Antz, M., Ernst, S., Cappato, R., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01767-3 · Cited by 556
Hayashi, M., Denjoy, I., Extramiana, F., Maltret, A., Buisson, N. R., Lupoglazoff, J.-M., Klug, D., Hayashi, M., Takatsuki, S., Villain, E., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.829267 · Cited by 555
Allelic Variants in Long-QT Disease Genes in Patients With Drug-Associated Torsades de Pointes
Yang, P., Kanki, H., Drolet, B., Yang, T., Wei, J., Viswanathan, P. C., Hohnloser, S. H., Shimizu, W., Schwartz, P. J., Stanton, M., et al. (2002) · Circulation · doi:10.1161/01.cir.0000014448.19052.4c · Cited by 554
Kawai, C. (1999) · Circulation · doi:10.1161/01.cir.99.8.1091 · Cited by 552
Sen-Chowdhry, S., Syrris, P., Ward, D., Asimaki, A., Sevdalis, E., & McKenna, W. J. (2007) · Circulation · doi:10.1161/circulationaha.106.660241 · Cited by 551
Cost-Effectiveness of Implantable Cardioverter–Defibrillators
Sanders, G. D., Hlatky, M. A., & Owens, D. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa051989 · Cited by 547
Self-citationSports-Related Sudden Death in the General Population
Marijon, E., Tafflet, M., Celermajer, D. S., Dumas, F., Perier, M.-C., Mustafic, H., Toussaint, J.-F., Desnos, M., Rieu, M., Benameur, N., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.008979 · Cited by 543
Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy
Monserrat, L., Elliott, P. M., Gimeno, J. R., Sharma, S., Penas-Lado, M., & McKenna, W. J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00827-1 · Cited by 541
Weisfeldt, M. L., Sitlani, C. M., Ornato, J. P., Rea, T., Aufderheide, T. P., Davis, D., Dreyer, J., Hess, E. P., Jui, J., Maloney, J., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.11.077 · Cited by 538
Wellens, H. J. J., Bär, F. W. H. M., & Lie, K. I. (1978) · The American Journal of Medicine · doi:10.1016/0002-9343(78)90176-6 · Cited by 538
Research works printed but not linked: 286
- Priori, 2016, G Ital Cardiol (Rome), 17, 108
- Link, 2015, Circulation, 132, e334
- Tabereaux, 2009, Mechanisms of VF maintenance: wandering wavelets, mother rotors, or foci, Heart Rhythm, 6, 405, 10.1016/j.hrthm.2008.11.005 · doi:10.1016/j.hrthm.2008.11.005
- Zhang, 2016, Electrophysiologic scar substrate in relation to VT: noninvasive high-resolution mapping and risk assessment with ECGI, Pacing Clin Electrophysiol, 39, 781, 10.1111/pace.12882 · doi:10.1111/pace.12882
- Myerburg, 2015, Cardiac arrest and sudden cardiac death - Chapter 39, 821
- Noda, 2005, Malignant entity of idiopathic ventricular fibrillation and polymorphic ventricular tachycardia initiated by premature extrasystoles originating from the right ventricular outflow tract, J Am Coll Cardiol, 46, 1288, 10.1016/j.jacc.2005.05.077 · DOI · Paper page
- Viskin, 2005, The “short-coupled” variant of right ventricular outflow ventricular tachycardia: a not-so-benign form of benign ventricular tachycardia?, J Cardiovasc Electrophysiol, 16, 912, 10.1111/j.1540-8167.2005.50040.x · DOI · Paper page
- Nordhues, 2016, Bileaflet mitral valve prolapse and risk of ventricular dysrhythmias and death, J Cardiovasc Electrophysiol, 27, 463, 10.1111/jce.12914 · doi:10.1111/jce.12914
- Linzer, 1990, Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope, Am J Cardiol, 66, 214, 10.1016/0002-9149(90)90591-N · DOI · Paper page
- Turakhia, 2013, Diagnostic utility of a novel leadless arrhythmia monitoring device, Am J Cardiol, 112, 520, 10.1016/j.amjcard.2013.04.017 · DOI · Paper page
- Dintzis, 1991, Genetic variation and the meiotic process, Res Publ Assoc Res Nerv Ment Dis, 69, 39
- Priori, 2013, HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes, Heart Rhythm, 10, 1932, 10.1016/j.hrthm.2013.05.014 · DOI · Paper page
- Laedtke, 2012, Family physicians' awareness and knowledge of the Genetic Information Non-Discrimination Act (GINA), J Genet Couns, 21, 345, 10.1007/s10897-011-9405-6 · DOI
- Costantini, 2009, The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention, J Am Coll Cardiol, 53, 471, 10.1016/j.jacc.2008.08.077 · DOI · Paper page
- Walker, 2005, Burst bicycle exercise facilitates diagnosis of latent long QT syndrome, Am Heart J, 150, 1059, 10.1016/j.ahj.2005.02.041 · doi:10.1016/j.ahj.2005.02.041
- Nannenberg, 2012, Mortality of inherited arrhythmia syndromes: insight into their natural history, Circ Cardiovasc Genet, 5, 183, 10.1161/CIRCGENETICS.111.961102 · DOI
- Zareba, 2017, Ranolazine in High-Risk ICD Patients (RAID) Trial, Presented at: Heart Rhythm Society Annual Scientific Sessions
- Hirsowitz, 1986, The role of beta blocking agents as adjunct therapy to membrane stabilizing drugs in malignant ventricular arrhythmia, Am Heart J, 111, 852, 10.1016/0002-8703(86)90633-2 · doi:10.1016/0002-8703(86)90633-2
- Bardy, 2005, Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure, N Engl J Med, 352, 225, 10.1056/NEJMoa043399 · DOI · Paper page
- Rauch, 2010, OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction, Circulation, 122, 2152, 10.1161/CIRCULATIONAHA.110.948562 · DOI · Paper page
- Yancy, 2016, J Am Coll Cardiol, 68, 1476, 10.1016/j.jacc.2016.05.011 · DOI · Paper page
- 1999, The cardiac insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial, Lancet, 353, 9, 10.1016/S0140-6736(98)11181-9 · DOI · Paper page
- Packer, 1996, The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group, N Engl J Med, 334, 1349, 10.1056/NEJM199605233342101 · DOI · Paper page
- Dumas, 2016, Emergency PCI in post-cardiac arrest patients without ST-segment elevation pattern: insights from the PROCAT II registry, J Am Coll Cardiol Intv, 9, 1011, 10.1016/j.jcin.2016.02.001 · DOI · Paper page
- Ngaage, 2008, Early and late survival after surgical revascularization for ischemic ventricular fibrillation/tachycardia, Ann Thorac Surg, 85, 1278, 10.1016/j.athoracsur.2007.12.035 · doi:10.1016/j.athoracsur.2007.12.035
- Layser, 2016, Anomalous coronary arteries: analysis of clinical outcome based upon arterial course and surgical intervention in an adult population, Acad Radiol, 23, 1015, 10.1016/j.acra.2016.03.020 · doi:10.1016/j.acra.2016.03.020
- Krittayaphong, 2002, Effect of atenolol on symptomatic ventricular arrhythmia without structural heart disease: a randomized placebo-controlled study, Am Heart J, 144, e10, 10.1067/mhj.2002.125516 · DOI
- Dorian, 2002, Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation, N Engl J Med, 346, 884, 10.1056/NEJMoa013029 · DOI · Paper page
- Kudenchuk, 2016, Amiodarone, lidocaine, or placebo in out-of-hospital cardiac arrest, N Engl J Med, 1711, 10.1056/NEJMoa1514204 · DOI · Paper page
- Kudenchuk, 1999, Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation, N Engl J Med, 341, 871, 10.1056/NEJM199909163411203 · DOI · Paper page
- Spaulding, 1997, Immediate coronary angiography in survivors of out-of-hospital cardiac arrest, N Engl J Med, 336, 1629, 10.1056/NEJM199706053362302 · DOI · Paper page
- Cronier, 2011, Impact of routine percutaneous coronary intervention after out-of-hospital cardiac arrest due to ventricular fibrillation, Crit Care, 15, 10.1186/cc10227 · DOI
- Zanuttini, 2012, Impact of emergency coronary angiography on in-hospital outcome of unconscious survivors after out-of-hospital cardiac arrest, Am J Cardiol, 110, 1723, 10.1016/j.amjcard.2012.08.006 · DOI
- Dumas, 2016, Emergency PCI in post-cardiac arrest patients without ST-segment elevation pattern: insights from the PROCAT II registry, J Am Coll Cardiol Intv, 9, 1011, 10.1016/j.jcin.2016.02.001 · DOI · Paper page
- Nademanee, 2000, Treating electrical storm: sympathetic blockade versus advanced cardiac life support-guided therapy, Circulation, 102, 742, 10.1161/01.CIR.102.7.742 · DOI · Paper page
- Belhassen, 1984, Use of intravenous verapamil for ventricular tachycardia, Am J Cardiol, 54, 1131, 10.1016/S0002-9149(84)80158-7 · DOI
- Buxton, 1987, Hazards of intravenous verapamil for sustained ventricular tachycardia, Am J Cardiol, 59, 1107, 10.1016/0002-9149(87)90857-5 · DOI
- Zipes, 2006, J Am Coll Cardiol, 48, e247, 10.1016/j.jacc.2006.07.010 · DOI · Paper page
- Perkins, 2015, Circulation, 132, 1286, 10.1161/CIR.0000000000000144 · DOI · Paper page
- Link, 2015, Circulation, 132, e334
- Joglar, 2016, Out-of-hospital cardiac arrest–are drugs ever the answer?, N Engl J Med, 374, 1781, 10.1056/NEJMe1602790 · doi:10.1056/nejme1602790
- 1997, A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias, N Engl J Med, 337, 1576, 10.1056/NEJM199711273372202 · DOI · Paper page
- Connolly, 2000, Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study, Eur Heart J, 21, 2071, 10.1053/euhj.2000.2476 · DOI · Paper page
- Anderson, 2014, ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines, J Am Coll Cardiol, 63, 2304, 10.1016/j.jacc.2014.03.016 · DOI · Paper page
- Morikawa, 2010, Letter by Morikawa et al regarding article, “coronary artery spasm: a 2009 update”, Circulation, 121, e16, 10.1161/CIR.0b013e3181ce1bcc · doi:10.1161/cir.0b013e3181ce1bcc
- Ascione, 2004, Predictors of new malignant ventricular arrhythmias after coronary surgery: a case-control study, J Am Coll Cardiol, 43, 1630, 10.1016/j.jacc.2003.11.056 · DOI
- Saxon, 1995, Monomorphic versus polymorphic ventricular tachycardia after coronary artery bypass grafting, Am J Cardiol, 75, 403, 10.1016/S0002-9149(99)80566-9 · doi:10.1016/s0002-9149(99)80566-9
- Bardy, 2005, Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure, N Engl J Med, 352, 225, 10.1056/NEJMoa043399 · DOI · Paper page
- Moss, 2002, Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction, N Engl J Med, 346, 877, 10.1056/NEJMoa013474 · DOI · Paper page
- Moss, 1996, Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators, N Engl J Med, 335, 1933, 10.1056/NEJM199612263352601 · DOI · Paper page
- Owens, 2002, Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator, Am Heart J, 144, 440, 10.1067/mhj.2002.125501 · DOI
- Buxton, 1999, A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators, N Engl J Med, 341, 1882, 10.1056/NEJM199912163412503 · DOI · Paper page
- Buxton, 2006, ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards, J Am Coll Cardiol, 48, 2360, 10.1016/j.jacc.2006.09.020 · DOI · Paper page
- Anderson, 2014, ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines, J Am Coll Cardiol, 63, 2304, 10.1016/j.jacc.2014.03.016 · DOI · Paper page
- Buxton, 2000, Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators, N Engl J Med, 342, 1937, 10.1056/NEJM200006293422602 · DOI · Paper page
- Kusumoto, 2014, HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials, J Am Coll Cardiol, 64, 1143, 10.1016/j.jacc.2014.04.008 · DOI · Paper page
- Sapp, 2016, Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs, N Engl J Med, 375, 111, 10.1056/NEJMoa1513614 · DOI · Paper page
- Echt, 1991, Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial, N Engl J Med, 324, 781, 10.1056/NEJM199103213241201 · DOI · Paper page
- Steinberg, 1999, New-onset sustained ventricular tachycardia after cardiac surgery, Circulation, 99, 903, 10.1161/01.CIR.99.7.903 · DOI
- Claro, 2015, Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death, Cochrane Database Syst Rev, 12
- Bunch, 2011, Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks, Pacing Clin Electrophysiol, 34, 1600, 10.1111/j.1540-8159.2011.03208.x · DOI · Paper page
- 1992, Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. The Cardiac Arrhythmia Suppression Trial II Investigators, N Engl J Med, 327, 227, 10.1056/NEJM199207233270403 · DOI · Paper page
- Kuck, 2000, Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH), Circulation, 102, 748, 10.1161/01.CIR.102.7.748 · DOI · Paper page
- Berntsen, 1993, Surgical revascularization in the treatment of ventricular tachycardia and fibrillation exposed by exercise-induced ischaemia, Eur Heart J, 14, 1297, 10.1093/eurheartj/14.10.1297 · doi:10.1093/eurheartj/14.10.1297
- Greulich, 2013, CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis, J Am Coll Cardiol Img, 6, 501, 10.1016/j.jcmg.2012.10.021 · DOI · Paper page
- Piers, 2013, Contrast-enhanced MRI-derived scar patterns and associated ventricular tachycardias in nonischemic cardiomyopathy: implications for the ablation strategy, Circ Arrhythm Electrophysiol, 6, 875, 10.1161/CIRCEP.113.000537 · DOI · Paper page
- Ackerman, 2011, HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA), Europace, 13, 1077, 10.1093/europace/eur245 · DOI · Paper page
- Coleman, 2016, Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis: a systematic review and meta-analysis, J Am Coll Cardiol Img
- 1997, A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias, N Engl J Med, 337, 1576, 10.1056/NEJM199711273372202 · DOI · Paper page
- Kuck, 2000, Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH), Circulation, 102, 748, 10.1161/01.CIR.102.7.748 · DOI · Paper page
- Raitt, 2001, “Stable” ventricular tachycardia is not a benign rhythm: insights from the Antiarrhythmics versus Implantable Defibrillators (AVID) registry, Circulation, 103, 244, 10.1161/01.CIR.103.2.244 · DOI
- Middlekauff, 1993, Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope, J Am Coll Cardiol, 21, 110, 10.1016/0735-1097(93)90724-F · DOI · Paper page
- Claro, 2015, Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death, Cochrane Database Syst Rev, 12
- Gatzoulis, 2013, Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation, Circ Arrhythm Electrophysiol, 6, 504, 10.1161/CIRCEP.113.000216 · DOI
- Hilfiker, 2015, Utility of electrophysiological studies to predict arrhythmic events, World J Cardiol, 7, 344, 10.4330/wjc.v7.i6.344 · DOI
- Thomas, 2008, Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality, Am Heart J, 155, 87, 10.1016/j.ahj.2007.09.010 · DOI
- Bardy, 2005, Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure, N Engl J Med, 352, 225, 10.1056/NEJMoa043399 · DOI · Paper page
- Bristow, 2004, Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure, N Engl J Med, 350, 2140, 10.1056/NEJMoa032423 · DOI · Paper page
- Desai, 2004, Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials, JAMA, 292, 2874, 10.1001/jama.292.23.2874 · DOI · Paper page
- Kadish, 2004, Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy, N Engl J Med, 350, 2151, 10.1056/NEJMoa033088 · DOI · Paper page
- Anselme, 2013, Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders, Heart Rhythm, 10, 1492, 10.1016/j.hrthm.2013.06.020 · DOI
- Pasotti, 2008, Long-term outcome and risk stratification in dilated cardiolaminopathies, J Am Coll Cardiol, 52, 1250, 10.1016/j.jacc.2008.06.044 · DOI · Paper page
- Van Berlo, 2005, Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death?, J Mol Med, 83, 79, 10.1007/s00109-004-0589-1 · DOI · Paper page
- van Rijsingen, 2012, Risk factors for malignant ventricular arrhythmias in lamin A/C mutation carriers: a European cohort study, J Am Coll Cardiol, 59, 493, 10.1016/j.jacc.2011.08.078 · DOI · Paper page
- Connolly, 2006, Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial, JAMA, 295, 165, 10.1001/jama.295.2.165 · DOI · Paper page
- Tung, 2015, Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: an International VT Ablation Center Collaborative Group study, Heart Rhythm, 12, 1997, 10.1016/j.hrthm.2015.05.036 · DOI · Paper page
- Piers, 2013, Contrast-enhanced MRI-derived scar patterns and associated ventricular tachycardias in nonischemic cardiomyopathy: implications for the ablation strategy, Circ Arrhythm Electrophysiol, 6, 875, 10.1161/CIRCEP.113.000537 · DOI · Paper page
- Groeneweg, 2015, Clinical presentation, long-term follow-up, and outcomes of 1001 arrhythmogenic right ventricular dysplasia/cardiomyopathy patients and family members, Circ Cardiovasc Genet, 8, 437, 10.1161/CIRCGENETICS.114.001003 · DOI · Paper page
- Marcus, 2013, Genetics of arrhythmogenic right ventricular cardiomyopathy: a practical guide for physicians, J Am Coll Cardiol, 61, 1945, 10.1016/j.jacc.2013.01.073 · DOI · Paper page
- Quarta, 2011, Familial evaluation in arrhythmogenic right ventricular cardiomyopathy: impact of genetics and revised task force criteria, Circulation, 123, 2701, 10.1161/CIRCULATIONAHA.110.976936 · DOI · Paper page
- Hershberger, 2009, Genetic evaluation of cardiomyopathy–a Heart Failure Society of America practice guideline, J Card Fail, 15, 83, 10.1016/j.cardfail.2009.01.006 · DOI · Paper page
- Rigato, 2013, Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy, Circ Cardiovasc Genet, 6, 533, 10.1161/CIRCGENETICS.113.000288 · DOI · Paper page
- van Rijsingen, 2012, Risk factors for malignant ventricular arrhythmias in lamin A/C mutation carriers: a European cohort study, J Am Coll Cardiol, 59, 493, 10.1016/j.jacc.2011.08.078 · DOI · Paper page
- Christiaans, 2009, Genetic counseling and cardiac care in predictively tested hypertrophic cardiomyopathy mutation carriers: the patients' perspective, Am J Med Genet, 149a, 1444, 10.1002/ajmg.a.32915 · DOI
- Hamang, 2012, Predictors of heart-focused anxiety in patients undergoing genetic investigation and counseling of long QT syndrome or hypertrophic cardiomyopathy: a one year follow-up, J Genet Counsel, 21, 72, 10.1007/s10897-011-9393-6 · DOI
- Zhu, 1998, The value of electrophysiology study and prophylactic implantation of cardioverter defibrillator in patients with hypertrophic cardiomyopathy, Pacing Clin Electrophysiol, 21, 299, 10.1111/j.1540-8159.1998.tb01109.x · DOI
- Gersh, 2011, J Am Coll Cardiol, 58, e212, 10.1016/j.jacc.2011.06.011 · DOI · Paper page
- Saeed, 2001, Role of invasive electrophysiologic testing in risk stratification for sudden cardiac death, J Invasive Cardiol, 13, 758
- Winkel, 2002, Myocarditis. Curr Treat Options, Cardiovasc Med, 4, 455
- Huang, 2013, Acute myocarditis and ventricular fibrillation as initial presentation of pediatric systemic lupus erythematosus, Rheumatol Int, 33, 1093, 10.1007/s00296-011-2240-0 · doi:10.1007/s00296-011-2240-0
- Muratore, 1997, Implantable cardioverter defibrillators in patients with Chagas' disease: are they different from patients with coronary disease?, Pacing Clin Electrophysiol, 20, 194, 10.1111/j.1540-8159.1997.tb04841.x · doi:10.1111/j.1540-8159.1997.tb04841.x
- d'Avila, 2002, New perspectives on catheter-based ablation of ventricular tachycardia complicating Chagas' disease: experimental evidence of the efficacy of near infrared lasers for catheter ablation of Chagas' VT, J Interv Card Electrophysiol, 7, 23, 10.1023/A:1020811915133 · doi:10.1023/a:1020811915133
- Coleman, 2016, Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis: a systematic review and meta-analysis, J Am Coll Cardiol Img, 10, 411, 10.1016/j.jcmg.2016.05.009 · DOI · Paper page
- Greulich, 2013, CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis, J Am Coll Cardiol Img, 6, 501, 10.1016/j.jcmg.2012.10.021 · DOI · Paper page
- Naruse, 2014, Systematic treatment approach to ventricular tachycardia in cardiac sarcoidosis, Circ Arrhythm Electrophysiol, 7, 407, 10.1161/CIRCEP.113.000734 · DOI
- Birnie, 2014, HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis, Heart Rhythm, 11, 1305, 10.1016/j.hrthm.2014.03.043 · DOI · Paper page
- Frohlich, 2013, Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation, Heart, 99, 1158, 10.1136/heartjnl-2013-304185 · DOI
- Kao, 2012, Wearable defibrillator use in heart failure (WIF): results of a prospective registry, BMC Cardiovasc Disord, 12, 123, 10.1186/1471-2261-12-123 · DOI
- Vakil, 2017, Impact of implantable cardioverter-defibrillators on waitlist mortality among patients awaiting heart transplantation. An UNOS/OPTN Analysis, JACC Clin Electrophysiol, 3, 33, 10.1016/j.jacep.2016.07.010 · DOI
- 1999, Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF), Lancet, 353, 2001, 10.1016/S0140-6736(99)04440-2 · DOI · Paper page
- Pitt, 2003, Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction, N Engl J Med, 348, 1309, 10.1056/NEJMoa030207 · DOI · Paper page
- Desai, 2015, Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients, Eur Heart J, 36, 1990, 10.1093/eurheartj/ehv186 · DOI · Paper page
- Vakil, 2016, Implantable cardioverter-defibrillator use in patients with left ventricular assist devices: a systematic review and meta-analysis, JACC Heart Fail, 4, 772, 10.1016/j.jchf.2016.05.003 · DOI
- Cantillon, 2010, Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator, Heart Rhythm, 7, 466, 10.1016/j.hrthm.2009.12.022 · doi:10.1016/j.hrthm.2009.12.022
- Slaughter, 2011, Destination therapy with left ventricular assist devices: patient selection and outcomes, Curr Opin Cardiol, 26, 232, 10.1097/HCO.0b013e328345aff4 · doi:10.1097/hco.0b013e328345aff4
- Anselme, 2013, Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders, Heart Rhythm, 10, 1492, 10.1016/j.hrthm.2013.06.020 · DOI
- van Rijsingen, 2012, Risk factors for malignant ventricular arrhythmias in lamin A/C mutation carriers: a European cohort study, J Am Coll Cardiol, 59, 493, 10.1016/j.jacc.2011.08.078 · DOI · Paper page
- Meune, 2006, Primary prevention of sudden death in patients with lamin A/C gene mutations, N Engl J Med, 354, 209, 10.1056/NEJMc052632 · DOI · Paper page
- Pasotti, 2008, Long-term outcome and risk stratification in dilated cardiolaminopathies, J Am Coll Cardiol, 52, 1250, 10.1016/j.jacc.2008.06.044 · DOI · Paper page
- Van Berlo, 2005, Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death?, J Mol Med, 83, 79, 10.1007/s00109-004-0589-1 · DOI · Paper page
- Epstein, 2008, J Am Coll Cardiol, 51, e1, 10.1016/j.jacc.2008.02.032 · DOI · Paper page
- Kumar, 2016, Long-term arrhythmic and nonarrhythmic outcomes of lamin A/C mutation carriers, J Am Coll Cardiol, 68, 2299, 10.1016/j.jacc.2016.08.058 · DOI · Paper page
- Goldenberg, 2011, Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals, J Am Coll Cardiol, 57, 51, 10.1016/j.jacc.2010.07.038 · DOI · Paper page
- Nannenberg, 2012, Mortality of inherited arrhythmia syndromes: insight into their natural history, Circ Cardiovasc Genet, 5, 183, 10.1161/CIRCGENETICS.111.961102 · DOI
- Priori, 2002, Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia, Circulation, 106, 69, 10.1161/01.CIR.0000020013.73106.D8 · DOI · Paper page
- Wedekind, 2009, QT interval prolongation and risk for cardiac events in genotyped LQTS-index children, Eur J Pediatr, 168, 1107, 10.1007/s00431-008-0896-6 · DOI
- Kaufman, 2008, Risk of death in the long QT syndrome when a sibling has died, Heart Rhythm, 5, 831, 10.1016/j.hrthm.2008.02.029 · DOI
- Kimbrough, 2001, Clinical implications for affected parents and siblings of probands with long-QT syndrome, Circulation, 104, 557, 10.1161/hc3001.093501 · DOI
- Hobbs, 2006, Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome, JAMA, 296, 1249, 10.1001/jama.296.10.1249 · DOI · Paper page
- Priori, 2004, Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers, JAMA, 292, 1341, 10.1001/jama.292.11.1341 · DOI · Paper page
- Priori, 2003, Risk stratification in the long-QT syndrome, N Engl J Med, 348, 1866, 10.1056/NEJMoa022147 · DOI · Paper page
- Paludan-Muller, 2017, Integration of 60,000 exomes and ACMG guidelines question the role of catecholaminergic polymorphic ventricular tachycardia-associated variants, Clin Genet, 91, 63, 10.1111/cge.12847 · DOI
- Giustetto, 2011, Long-term follow-up of patients with short QT syndrome, J Am Coll Cardiol, 58, 587, 10.1016/j.jacc.2011.03.038 · DOI · Paper page
- Mahida, 2015, Role of electrophysiological studies in predicting risk of ventricular arrhythmia in early repolarization syndrome, J Am Coll Cardiol, 65, 151, 10.1016/j.jacc.2014.10.043 · DOI
- Mazzanti, 2014, Novel insight into the natural history of short QT syndrome, J Am Coll Cardiol, 63, 1300, 10.1016/j.jacc.2013.09.078 · DOI · Paper page
- Rodriguez-Manero, 2016, Monomorphic ventricular tachycardia in patients with Brugada syndrome: a multicenter retrospective study, Heart Rhythm, 13, 669, 10.1016/j.hrthm.2015.10.038 · DOI
- Moss, 2000, Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome, Circulation, 101, 616, 10.1161/01.CIR.101.6.616 · DOI · Paper page
- Vincent, 2009, High efficacy of beta-blockers in long-QT syndrome type 1: contribution of noncompliance and QT-prolonging drugs to the occurrence of beta-blocker treatment “failures”, Circulation, 119, 215, 10.1161/CIRCULATIONAHA.108.772533 · DOI · Paper page
- Hobbs, 2006, Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome, JAMA, 296, 1249, 10.1001/jama.296.10.1249 · DOI · Paper page
- Mazzanti, 2016, Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3, J Am Coll Cardiol, 67, 1053, 10.1016/j.jacc.2015.12.033 · DOI · Paper page
- Nannenberg, 2012, Mortality of inherited arrhythmia syndromes: insight into their natural history, Circ Cardiovasc Genet, 5, 183, 10.1161/CIRCGENETICS.111.961102 · DOI
- Wedekind, 2009, QT interval prolongation and risk for cardiac events in genotyped LQTS-index children, Eur J Pediatr, 168, 1107, 10.1007/s00431-008-0896-6 · DOI
- Hofferberth, 2014, Left thoracoscopic sympathectomy for cardiac denervation in patients with life-threatening ventricular arrhythmias. J Thorac Cardiovasc, Surg, 147, 404
- Bai, 2009, Yield of genetic screening in inherited cardiac channelopathies: how to prioritize access to genetic testing, Circ Arrhythm Electrophysiol, 2, 6, 10.1161/CIRCEP.108.782888 · DOI
- Costa, 2012, Combined assessment of sex- and mutation-specific information for risk stratification in type 1 long QT syndrome, Heart Rhythm, 9, 892, 10.1016/j.hrthm.2012.01.020 · DOI
- Kim, 2010, Trigger-specific risk factors and response to therapy in long QT syndrome type 2, Heart Rhythm, 7, 1797, 10.1016/j.hrthm.2010.09.011 · DOI
- Migdalovich, 2011, Mutation and gender-specific risk in type 2 long QT syndrome: implications for risk stratification for life-threatening cardiac events in patients with long QT syndrome, Heart Rhythm, 8, 1537, 10.1016/j.hrthm.2011.03.049 · DOI
- Priori, 2004, Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers, JAMA, 292, 1341, 10.1001/jama.292.11.1341 · DOI · Paper page
- Goldenberg, 2011, Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals, J Am Coll Cardiol, 57, 51, 10.1016/j.jacc.2010.07.038 · DOI · Paper page
- Priori, 2003, Risk stratification in the long-QT syndrome, N Engl J Med, 348, 1866, 10.1056/NEJMoa022147 · DOI · Paper page
- Wilde, 2016, Clinical aspects of type 3 long-QT syndrome: an international multicenter study, Circulation, 134, 872, 10.1161/CIRCULATIONAHA.116.021823 · DOI · Paper page
- Garson, 1993, The long QT syndrome in children. An international study of 287 patients, Circulation, 87, 1866, 10.1161/01.CIR.87.6.1866 · DOI · Paper page
- Dorostkar, 1999, Long-term follow-up of patients with long-QT syndrome treated with beta-blockers and continuous pacing, Circulation, 100, 2431, 10.1161/01.CIR.100.24.2431 · DOI
- Eldar, 1992, Combined use of beta-adrenergic blocking agents and long-term cardiac pacing for patients with the long QT syndrome, J Am Coll Cardiol, 20, 830, 10.1016/0735-1097(92)90180-U · DOI
- Moss, 1991, Efficacy of permanent pacing in the management of high-risk patients with long QT syndrome, Circulation, 84, 1524, 10.1161/01.CIR.84.4.1524 · DOI · Paper page
- Bos, 2013, Left cardiac sympathetic denervation in long QT syndrome: analysis of therapeutic nonresponders, Circ Arrhythm Electrophysiol, 6, 705, 10.1161/CIRCEP.113.000102 · doi:10.1161/circep.113.000102
- Li, 2008, Video-assisted thoracoscopic left cardiac sympathetic denervation: a reliable minimally invasive approach for congenital long-QT syndrome, Ann Thorac Surg, 86, 1955, 10.1016/j.athoracsur.2008.07.100 · doi:10.1016/j.athoracsur.2008.07.100
- Zhang, 2015, Identification of low-risk adult congenital LQTS patients, J Cardiovasc Electrophysiol, 26, 853, 10.1111/jce.12686 · doi:10.1111/jce.12686
- Spazzolini, 2009, Clinical implications for patients with long QT syndrome who experience a cardiac event during infancy, J Am Coll Cardiol, 54, 832, 10.1016/j.jacc.2009.05.029 · DOI
- Hayashi, 2009, Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia, Circulation, 119, 2426, 10.1161/CIRCULATIONAHA.108.829267 · DOI · Paper page
- Collura, 2009, Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery, Heart Rhythm, 6, 752, 10.1016/j.hrthm.2009.03.024 · DOI · Paper page
- Schneider, 2013, Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome, Clin Res Cardiol, 102, 33, 10.1007/s00392-012-0492-7 · DOI
- Priori, 2002, Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia, Circulation, 106, 69, 10.1161/01.CIR.0000020013.73106.D8 · DOI · Paper page
- Adler, 2016, Patient outcomes from a specialized inherited arrhythmia clinic, Circ Arrhythm Electrophysiol, 9, e003440, 10.1161/CIRCEP.115.003440 · DOI
- Olde Nordkamp, 2016, Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: a systematic review and meta-analysis of inappropriate shocks and complications, Heart Rhythm, 13, 443, 10.1016/j.hrthm.2015.09.010 · DOI · Paper page
- De Ferrari, 2015, Clinical management of catecholaminergic polymorphic ventricular tachycardia: the role of left cardiac sympathetic denervation, Circulation, 131, 2185, 10.1161/CIRCULATIONAHA.115.015731 · DOI · Paper page
- Wilde, 2008, Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia, N Engl J Med, 358, 2024, 10.1056/NEJMoa0708006 · DOI · Paper page
- Zhang, 2015, Long-QT syndrome and therapy for attention deficit/hyperactivity disorder, J Cardiovasc Electrophysiol, 26, 1039, 10.1111/jce.12739 · DOI
- Jabbari, 2013, New exome data question the pathogenicity of genetic variants previously associated with catecholaminergic polymorphic ventricular tachycardia, Circ Cardiovasc Genetics, 6, 481, 10.1161/CIRCGENETICS.113.000118 · DOI
- Paludan-Muller, 2017, Integration of 60,000 exomes and acmg guidelines question the role of catecholaminergic polymorphic ventricular tachycardia-associated variants, Clin Genet, 91, 63, 10.1111/cge.12847 · DOI
- Gehi, 2006, Risk stratification of individuals with the Brugada electrocardiogram: a meta-analysis, J Cardiovasc Electrophysiol, 17, 577, 10.1111/j.1540-8167.2006.00455.x · DOI · Paper page
- Hiraoka, 2013, Prognosis and risk stratification of young adults with Brugada syndrome, J Electrocardiol, 46, 279, 10.1016/j.jelectrocard.2013.04.003 · DOI
- Priori, 2012, Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry, J Am Coll Cardiol, 59, 37, 10.1016/j.jacc.2011.08.064 · DOI · Paper page
- Probst, 2010, Long-term prognosis of patients diagnosed with Brugada syndrome: results from the FINGER Brugada syndrome registry, Circulation, 121, 635, 10.1161/CIRCULATIONAHA.109.887026 · DOI · Paper page
- Delise, 2011, Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach, Eur Heart J, 32, 169, 10.1093/eurheartj/ehq381 · DOI · Paper page
- Kusumoto, 2018, J Am Coll Cardiol, 72, 1653, 10.1016/j.jacc.2017.10.052 · DOI
- Crotti, 2012, Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: implications for genetic testing, J Am Coll Cardiol, 60, 1410, 10.1016/j.jacc.2012.04.037 · DOI · Paper page
- Probst, 2009, SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome, Circ Cardiovasc Genet, 2, 552, 10.1161/CIRCGENETICS.109.853374 · DOI · Paper page
- Risgaard, 2013, High prevalence of genetic variants previously associated with Brugada syndrome in new exome data, Clinical Genetics, 84, 489, 10.1111/cge.12126 · DOI
- Priori, 2013, HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes, Heart Rhythm, 10, 1932, 10.1016/j.hrthm.2013.05.014 · DOI · Paper page
- Rodriguez-Manero, 2016, Monomorphic ventricular tachycardia in patients with Brugada syndrome: a multicenter retrospective study, Heart Rhythm, 13, 669, 10.1016/j.hrthm.2015.10.038 · DOI
- Conte, 2015, Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience, J Am Coll Cardiol, 65, 879, 10.1016/j.jacc.2014.12.031 · DOI · Paper page
- Priori, 2002, Natural history of Brugada syndrome: insights for risk stratification and management, Circulation, 105, 1342, 10.1161/hc1102.105288 · DOI · Paper page
- Siebermair, 2016, Early repolarization pattern is the strongest predictor of arrhythmia recurrence in patients with idiopathic ventricular fibrillation: results from a single centre long-term follow-up over 20 years, Europace, 18, 718, 10.1093/europace/euv301 · DOI
- Giustetto, 2011, Long-term follow-up of patients with short QT syndrome, J Am Coll Cardiol, 58, 587, 10.1016/j.jacc.2011.03.038 · DOI · Paper page
- Mazzanti, 2014, Novel insight into the natural history of short QT syndrome, J Am Coll Cardiol, 63, 1300, 10.1016/j.jacc.2013.09.078 · DOI · Paper page
- Giustetto, 2006, Short QT syndrome: clinical findings and diagnostic-therapeutic implications, Eur Heart J, 27, 2440, 10.1093/eurheartj/ehl185 · DOI · Paper page
- Iribarren, 2014, Short QT in a cohort of 1.7 million persons: prevalence, correlates, and prognosis, Ann Noninvasive Electrocardiol, 19, 490, 10.1111/anec.12157 · DOI
- Gollob, 2011, Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian Cardiovascular Society/Canadian Heart Rhythm Society joint position paper, Can J Cardiol, 27, 232, 10.1016/j.cjca.2010.12.078 · DOI
- Gill, 1993, Verapamil for the suppression of idiopathic ventricular tachycardia of left bundle branch block-like morphology, Am Heart J, 126, 1126, 10.1016/0002-8703(93)90664-U · DOI
- Gill, 1992, Comparison of verapamil and diltiazem in the suppression of idiopathic ventricular tachycardia, Pacing Clin Electrophysiol, 15, 2122, 10.1111/j.1540-8159.1992.tb03033.x · DOI
- Kontos, 2011, Treatment and outcomes in patients with myocardial infarction treated with acute beta–blocker therapy: results from the American College of Cardiology's NCDR(R), Am Heart J, 161, 864, 10.1016/j.ahj.2011.01.006 · DOI
- Levine, 1996, Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group, J Am Coll Cardiol, 27, 67, 10.1016/0735-1097(95)00427-0 · DOI · Paper page
- Noda, 2005, Malignant entity of idiopathic ventricular fibrillation and polymorphic ventricular tachycardia initiated by premature extrasystoles originating from the right ventricular outflow tract, J Am Coll Cardiol, 46, 1288, 10.1016/j.jacc.2005.05.077 · DOI · Paper page
- Viskin, 2005, The “short-coupled” variant of right ventricular outflow ventricular tachycardia: a not-so-benign form of benign ventricular tachycardia?, J Cardiovasc Electrophysiol, 16, 912, 10.1111/j.1540-8167.2005.50040.x · DOI · Paper page
- Krittayaphong, 2002, Effect of atenolol on symptomatic ventricular arrhythmia without structural heart disease: a randomized placebo-controlled study, Am Heart J, 144, e10, 10.1067/mhj.2002.125516 · DOI
- Ling, 2014, Radiofrequency ablation versus antiarrhythmic medication for treatment of ventricular premature beats from the right ventricular outflow tract: prospective randomized study, Circ Arrhythm Electrophysiol, 7, 237, 10.1161/CIRCEP.113.000805 · DOI · Paper page
- Badhwar, 2007, Idiopathic ventricular tachycardia: diagnosis and management, Curr Probl Cardiol, 32, 7, 10.1016/j.cpcardiol.2006.10.002 · DOI
- Connolly, 1999, Meta-analysis of antiarrhythmic drug trials, Am J Cardiol, 84, 90R, 10.1016/S0002-9149(99)00708-0 · DOI
- Ling, 2014, Radiofrequency ablation versus antiarrhythmic medication for treatment of ventricular premature beats from the right ventricular outflow tract: prospective randomized study, Circ Arrhythm Electrophysiol, 7, 237, 10.1161/CIRCEP.113.000805 · DOI · Paper page
200 of 286 shown
Cited by
2023 ESC guidelines for the management of cardiomyopathies
Arbelo, E., Protonotarios, A., Gimeno, J. R., Arbustini, E., Barriales-Villa, R., Basso, C., Bezzina, C. R., Biagini, E., Blom, N. A., de Boer, R. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad194 · Cited by 2,844
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862
Self-citation2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization
Lawton, J. S., Tamis-Holland, J. E., Bangalore, S., Bates, E. R., Beckie, T. M., Bischoff, J. M., Bittl, J. A., Cohen, M. G., DiMaio, J. M., Don, C. W., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.09.006 · Cited by 1,558
The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030
Vogel, B., Acevedo, M., Appelman, Y., Bairey Merz, C. N., Chieffo, A., Figtree, G. A., Guerrero, M., Kunadian, V., Lam, C. S. P., Maas, A. H. E. M., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00684-x · Cited by 1,488
Attia, Z. I., Kapa, S., Lopez-Jimenez, F., McKie, P. M., Ladewig, D. J., Satam, G., Pellikka, P. A., Enriquez-Sarano, M., Noseworthy, P. A., Munger, T. M., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0240-2 · Cited by 1,389
Metadata
- Authors
- Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., Gillis, A. M., Granger, C. B., Hammill, S. C., Hlatky, M. A., Joglar, J. A., Kay, G. N., Matlock, D. D., Myerburg, R. J., & Page, R. L.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 72
- Issue
- 14
- Pages
- e91-e220
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2940793653
- Cited by
- 1,854
- References
- 1,025
- FWCI
- 144.51
- Type
- journal article
- Language
- en
- Update notices
- erratum (2018-10-02)
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 366 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.